vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Gogo Inc. (GOGO). Click either name above to swap in a different company.
Gogo Inc. is the larger business by last-quarter revenue ($230.6M vs $168.4M, roughly 1.4× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 67.3%). Over the past eight quarters, Gogo Inc.'s revenue compounded faster (48.7% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Gogo Inc. is an American provider of in-flight broadband Internet service and other connectivity services for business aircraft, headquartered in Broomfield, Colorado. Through its Gogo LLC subsidiary, Gogo previously provided in-flight WiFi to 17 airlines until the Commercial Air business was sold to Intelsat for $400 million in December 2020. According to Gogo, over 2,500 commercial aircraft and 6,600 business aircraft have been equipped with its onboard Wi-Fi services. The company is the de...
ESPR vs GOGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $230.6M |
| Net Profit | — | $-10.0M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | 6.2% |
| Net Margin | — | -4.3% |
| Revenue YoY | 143.7% | 67.3% |
| Net Profit YoY | — | 64.6% |
| EPS (diluted) | $0.32 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $230.6M | ||
| Q3 25 | $87.3M | $223.6M | ||
| Q2 25 | $82.4M | $226.0M | ||
| Q1 25 | $65.0M | $230.3M | ||
| Q4 24 | $69.1M | $137.8M | ||
| Q3 24 | $51.6M | $100.5M | ||
| Q2 24 | $73.8M | $102.1M | ||
| Q1 24 | $137.7M | $104.3M |
| Q4 25 | — | $-10.0M | ||
| Q3 25 | $-31.3M | $-1.9M | ||
| Q2 25 | $-12.7M | $12.8M | ||
| Q1 25 | $-40.5M | $12.0M | ||
| Q4 24 | — | $-28.2M | ||
| Q3 24 | $-29.5M | $10.6M | ||
| Q2 24 | $-61.9M | $839.0K | ||
| Q1 24 | $61.0M | $30.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 87.8% | ||
| Q1 25 | — | 87.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 50.6% | 6.2% | ||
| Q3 25 | -11.4% | 12.9% | ||
| Q2 25 | 8.6% | 15.9% | ||
| Q1 25 | -34.0% | 15.3% | ||
| Q4 24 | -6.4% | -17.5% | ||
| Q3 24 | -31.0% | 19.0% | ||
| Q2 24 | 3.5% | 21.2% | ||
| Q1 24 | 52.5% | 33.2% |
| Q4 25 | — | -4.3% | ||
| Q3 25 | -35.9% | -0.9% | ||
| Q2 25 | -15.4% | 5.7% | ||
| Q1 25 | -62.2% | 5.2% | ||
| Q4 24 | — | -20.5% | ||
| Q3 24 | -57.2% | 10.6% | ||
| Q2 24 | -83.9% | 0.8% | ||
| Q1 24 | 44.3% | 29.2% |
| Q4 25 | $0.32 | $-0.08 | ||
| Q3 25 | $-0.16 | $-0.01 | ||
| Q2 25 | $-0.06 | $0.09 | ||
| Q1 25 | $-0.21 | $0.09 | ||
| Q4 24 | $-0.14 | $-0.22 | ||
| Q3 24 | $-0.15 | $0.08 | ||
| Q2 24 | $-0.33 | $0.01 | ||
| Q1 24 | $0.34 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $125.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $101.1M |
| Total Assets | $465.9M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $125.2M | ||
| Q3 25 | $92.4M | $133.6M | ||
| Q2 25 | $86.1M | $102.1M | ||
| Q1 25 | $114.6M | $70.3M | ||
| Q4 24 | $144.8M | $41.8M | ||
| Q3 24 | $144.7M | $176.7M | ||
| Q2 24 | $189.3M | $161.6M | ||
| Q1 24 | $226.6M | $152.8M |
| Q4 25 | $-302.0M | $101.1M | ||
| Q3 25 | $-451.4M | $107.0M | ||
| Q2 25 | $-433.5M | $102.8M | ||
| Q1 25 | $-426.2M | $82.9M | ||
| Q4 24 | $-388.7M | $69.3M | ||
| Q3 24 | $-370.2M | $52.7M | ||
| Q2 24 | $-344.2M | $52.0M | ||
| Q1 24 | $-294.3M | $62.4M |
| Q4 25 | $465.9M | $1.3B | ||
| Q3 25 | $364.0M | $1.3B | ||
| Q2 25 | $347.1M | $1.3B | ||
| Q1 25 | $324.0M | $1.2B | ||
| Q4 24 | $343.8M | $1.2B | ||
| Q3 24 | $314.1M | $810.7M | ||
| Q2 24 | $352.3M | $802.7M | ||
| Q1 24 | $373.1M | $809.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $8.5M |
| Free Cash FlowOCF − Capex | — | $-25.4M |
| FCF MarginFCF / Revenue | — | -11.0% |
| Capex IntensityCapex / Revenue | 0.0% | 14.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $65.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $8.5M | ||
| Q3 25 | $-4.3M | $46.8M | ||
| Q2 25 | $-31.4M | $36.7M | ||
| Q1 25 | $-22.6M | $32.5M | ||
| Q4 24 | $-35.0M | $-38.3M | ||
| Q3 24 | $-35.3M | $25.1M | ||
| Q2 24 | $-7.2M | $24.9M | ||
| Q1 24 | $53.8M | $29.7M |
| Q4 25 | — | $-25.4M | ||
| Q3 25 | — | $27.3M | ||
| Q2 25 | — | $33.5M | ||
| Q1 25 | — | $29.7M | ||
| Q4 24 | — | $-42.6M | ||
| Q3 24 | $-35.5M | $20.7M | ||
| Q2 24 | $-7.3M | $21.6M | ||
| Q1 24 | $53.8M | $28.2M |
| Q4 25 | — | -11.0% | ||
| Q3 25 | — | 12.2% | ||
| Q2 25 | — | 14.8% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | — | -30.9% | ||
| Q3 24 | -68.7% | 20.6% | ||
| Q2 24 | -9.9% | 21.1% | ||
| Q1 24 | 39.0% | 27.0% |
| Q4 25 | 0.0% | 14.7% | ||
| Q3 25 | 0.0% | 8.7% | ||
| Q2 25 | 0.0% | 1.4% | ||
| Q1 25 | 0.0% | 1.2% | ||
| Q4 24 | 0.0% | 3.1% | ||
| Q3 24 | 0.3% | 4.4% | ||
| Q2 24 | 0.1% | 3.3% | ||
| Q1 24 | 0.1% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.87× | ||
| Q1 25 | — | 2.70× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.36× | ||
| Q2 24 | — | 29.74× | ||
| Q1 24 | 0.88× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
GOGO
| Services | $191.9M | 83% |
| Products | $38.7M | 17% |
| Fcc Reimbursement Program | $2.0M | 1% |
